跳至主要内容
临床试验/CTRI/2026/03/106030
CTRI/2026/03/106030尚未招募1 期

Phase 1 study of safety and feasibility of Bhanga (Cannabis sativa) churna in the Pre-operative period in oral cavity squamous cell cancer.

AYUSH CoE, Ministry of Ayush, Government of India2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2026年4月20日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
25
试验地点
2

研究概览

简要总结

Cancer is a serious disease that is growing very fast around the world. In 2020, about 1.9 crore new cancer cases were reported, and India had the third highest number, after China and the USA. By the year 2040, cancer cases in India may increase by 57%, reaching over 20 lakh people. One common type of cancer in India is mouth cancer, which is part of head and neck cancers. It spreads quickly, comes back after treatment, and is more common in poor or developing countries like India. In India, the traditional system of medicine called Ayurveda has long used herbs and plants to treat diseases. Ancient Ayurvedic books mention cancer-like illnesses as “Arbuda” (big swelling) or “Granthi” (small swelling). One such plant used in Ayurveda is Bhanga, also known as Cannabis sativa. Cannabis contains natural chemicals called cannabinoids, such as THC and CBD, which may help kill cancer cells, stop their growth, reduce spreading, and support the body’s immune system.These cannabinoids work by attaching to special parts of the body called receptors. Some studies in the lab and in animals have shown that cannabis can cause cancer cells to die and may reduce inflammation, but there are only a few studies in humans. Cannabis can be taken as a capsule or spray. Capsules are easy to take and help measure the correct dose. The effects may take about two hours to appear. Some side effects like dizziness or sleepiness have been reported, but most are mild. New studies suggest that natural cannabis may work better than lab-made versions because all parts of the plant work together to give better results. Our study aims to find out if Bhanga is safe to use before surgery in patients with mouth cancer. We will give Bhanga in powder (churna) form, following Ayurvedic methods. This research hopes to offer a safe, low-cost treatment that supports patients before and after surgery, along with their regular cancer care.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Histo-pathologically proven patients of oral cavity SCC.
  • Only clearly operable cancers planned to undergo upfront curative surgery.
  • Patient fit for surgery (ASA Grade I / II).
  • Patient voluntarily willing to give consent for study.

排除标准

  • 未提供

研究者

发起方
AYUSH CoE, Ministry of Ayush, Government of India
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr Vikram Gota

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)

研究点 (2)

Loading locations...

相似试验